Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors (clinicaltrials.gov) - Jul 18, 2026 - P1/2 | N=92 | Active, not recruiting | Sponsor: InventisBio Co., Ltd | Trial completion date: Dec 2025 ➔ Aug 2029 | Trial primary completion date: Jul 2025 ➔ Dec 2027
Trial completion date • Trial primary completion date • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS
|